Longevity Is Usually A Reward For Being Unspectacular
Mint Bangalore|January 06, 2025
Careers That Endure Are Typically Not Spectacular. This Is So In Politics As Well As Other Fields
MANU JOSEPH

In the end, what many tributes to Dr. Manmohan Singh tried to say, shorn of frills, was that the economist survived long in politics because he posed no political threat to his party's true power centre. He was so reassuring; he even lost the only Lok Sabha election he contested.

For a man who was said to be incapable of subterfuge or even office politics, a skill in which Indians excel, Dr. Singh thrived in public office. He had been governor of the Reserve Bank of India and our most famous finance minister before he became one of India's longest-serving prime ministers. And he could achieve all this not only because he had an economic vision, but chiefly because he was not politically extraordinary. His source of power was assured that he would always need them and that he would never develop another source.

Often, endurance is nature's reward to a person whose presence is not spectacular. This phenomenon can be seen in almost everything humans do.

This is why corporate bosses, even when they claim, "I only hire people who are smarter than me," typically don't do that at all, especially when that fact is too evident in the 'smarter' candidate. A nerd with narrow genius and no managerial prospects might fare well, but people whose presence or role is spectacular in a broad way do not go very far up the tapering hierarchy. Founders and entrepreneurs always pounce on super talent as they are at no threat of being eclipsed, but in a typical office, the calibre of a boss is often the upper limit for talent in his team.

هذه القصة مأخوذة من طبعة January 06, 2025 من Mint Bangalore.

ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.

هذه القصة مأخوذة من طبعة January 06, 2025 من Mint Bangalore.

ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.

المزيد من القصص من MINT BANGALORE مشاهدة الكل
Mint Bangalore

Nvidia Shows New Chips, Inks Toyota Deal for Robotic Cars

Shares of Toyota, Nvidia's suppliers rise on optimism about the AI chip maker's prospects

time-read
3 mins  |
January 08, 2025
Mint Bangalore

DIAL drops plea over Hindon ops expansion

Delhi International Airport Ltd (DIAL) on Tuesday withdrew its legal challenge against the Centre's decision to allow the Airports Authority of India (AAI) to operate scheduled commercial flights from the Indian Air Force Station in Hindon, Ghaziabad.

time-read
1 min  |
January 08, 2025
Mint Bangalore

Auto sales rise 9% in 2024 despite headwinds: Fada

Inventory build-up, delayed harvest payments, weak consumer sentiment weighed on demand in Dec

time-read
1 min  |
January 08, 2025
Mint Bangalore

Razorpay Charts Return to India; Eyes Expansion, IPO

Firm is likely to complete its reverse-flip in six months, with an IPO expected in two years

time-read
3 mins  |
January 08, 2025
Mint Bangalore

Bank profits set to moderate in FY26 as bad assets rise

Ind-Ra sharply revised down its FY25 system credit growth estimate to 13-13.5% from 15% earlier

time-read
2 mins  |
January 08, 2025
Mint Bangalore

Lloyds Metals shines on likely gains from acquisition, capex

Lloyds Metals & Energy Ltd's shares have gained about 15% so far in 2025 after the company's quarterly update and announcement of employee stock options (Esops) for its 6,000 workers.

time-read
1 min  |
January 08, 2025
Mint Bangalore

Another tough year for FMCG?

Feeling blue

time-read
2 mins  |
January 08, 2025
Mint Bangalore

Your fancy, new ETF might be a little too fancy

Exchange-traded funds have mostly been great investments, but they are getting too complex for their own good

time-read
4 mins  |
January 08, 2025
Mint Bangalore

Risks to economy escalating in 2025, cautions SBICAPS

Rising household debt, fluctuating FII flows among risks that threaten to amplify economic fragility: Report

time-read
1 min  |
January 08, 2025
Mint Bangalore

Intas Pharma bags another overseas company

Gujarat-based drug-maker Intas Pharmaceuticals Ltd., which counts private equity firm ChrysCapital, Singapore state investment firm Temasek, and Abu Dhabi Investment Authority (ADIA) as its investors, has signed a deal to acquire a biologic medication brand from US-based Coherus Biosciences.

time-read
1 min  |
January 08, 2025